Thank you for participating in the rheumatology board certification survey. Your feedback is critical for the ACR to understand whether you believe that rheumatology initial certification and MOC should remain with ABIM or move to ABAI with the formation of a new combined board of Allergy, Immunology and Rheumatology. We greatly value your opinion regarding this important issue of initial rheumatology board certification and MOC. We will provide the survey results in the coming months.
A Message from the ACR
Dear members of the rheumatology community,
I am writing to you with an important message about certification in rheumatology. This has been a significant area of concern for our members and the ACR has undertaken many efforts to address issues related to ongoing certification with the American Board of Internal Medicine (ABIM). These efforts have now led us once again ask you to contribute your voice on this issue. Read the letter
- David Daikh, MD, PhD
Exploring Certification: Getting Started
Find out who's who in certification, read about the value of board certification, and review some background on this highly charged topic.
ABIM and ABAI: Comparison and Considerations
Get the big picture before you take the survey. Our informational brief provides a clear understanding of this complex issue.
The ACR's Role
The ACR is in the process of seeking feedback from the membership and key stakeholders to better inform the discussion. The ultimate approval to move certification from ABIM to ABAI can only come from ABMS.
See Details About ACR's Role in Certification
Does certification have your head spinning? We've compiled a number of FAQs to help you navigate this complex issue.
Rheumatology Certification FAQs